CenterPoint Energy (CNP): Assessing Valuation Following Recent Gains and Investor Sentiment Shift
AI Sentiment
Positive
7/10
as of 11-28-2025 12:37pm EST
CenterPoint Energy owns a portfolio of businesses. Its regulated electric utilities provide transmission and distribution services to more than 2.5 million customers in the Houston area, southern Indiana, and west central Ohio. The company has natural gas distribution systems serving approximately 4 million customers.
| Founded: | 1866 | Country: | United States |
| Employees: | N/A | City: | HOUSTON |
| Market Cap: | 25.7B | IPO Year: | N/A |
| Target Price: | $41.29 | AVG Volume (30 days): | 4.6M |
| Analyst Decision: | Buy | Number of Analysts: | 12 |
| Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
| EPS: | 1.58 | EPS Growth: | 5.29 |
| 52 Week Low/High: | $30.59 - $40.50 | Next Earning Date: | 10-23-2025 |
| Revenue: | $9,114,000,000 | Revenue Growth: | 6.43% |
| Revenue Growth (this year): | 6.69% | Revenue Growth (next year): | 5.90% |
Machine learning model trained on 25+ technical indicators
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Director
Avg Cost/Share
$38.83
Shares
6,200
Total Value
$240,746.00
Owned After
65,577
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| Smith Phillip R | CNP | Director | Nov 6, 2025 | Sell | $38.83 | 6,200 | $240,746.00 | 65,577 |
CNP Breaking Stock News: Dive into CNP Ticker-Specific Updates for Smart Investing
AI Sentiment
Positive
7/10
AI Sentiment
Neutral
4/10
AI Sentiment
Highly Positive
8/10
See how CNP stacks up against similar companies in the market
Enhance your trading experience with our free tools
The information presented on this page, "CNP CenterPoint Energy Inc (Holding Co) - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.